Described herein are pharmaceutical packaging methods which protect against oxidative degradation of morphine, hydromorphone, promethazine as well as other oxygen-sensitive drugs, these programs including a syringe by having an oxygen permeable idea cap, a hermetically sealed oxygen barrier blister packaging with really minimal permeability to oxyg